from s&p sea world headquarter here in new york welcome to alex witt reports we begin this hour outside a serving court in washingto d.c. there you see protesters gathering, it s happening today, over the next few days as th showdown over reproductive rights returns to the nation s highest court. mifepristone, the drug at th center of this legal battle, remains available to women across the u.s., at least unti wednesday, while the court way the latest gop led efforts t ban the drug a new reaction this hour t comments made at the nra convention, including donald trump s remarks that mas shootings are not a gu problem. here s what to advocates for reform told my colleague jonathan capehart. camilla congress, and to se the cowardice from my go colleagues is just gross everyone is too comfortable. we walk around with our suits, we talk to our donors, w raised all of this money, an then we go on banded kne pandering to the nra are you kidding me the united states o america s o
until at least wednesday joining me now is rebecca professor law at york la school also former assistant district attorney of manhattan d.a. s office good to see you again, rebecca let s get into this because i curious, is it just buying tim for the supreme court to examine all the issues in th case where does it offer an indication of how the cour might rule it doesn t really offer any indication of how the cour might rule this is really a question of what is going to happen in the interim while this issue makes its way up through the courts. as you are just talking about, the case in dobbs, supreme courts last pronouncement on abortion rights, the court clearly said, this is an issue that ought to be decided by ou elected officials so the fallout that you were to speaking about is what was expected having the court way back in o a national issue, on the acces to this abortion dru nationally, it is, again something that was probably no